Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A-Reference-Cited by-同舟云学术

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A

Published:2008-11-06 Issue:12 Volume:8 Page:1885-1896
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Kruse-Jarres Rebecca,Barnett Brian,Leissinger Cindy

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712590802515537

Reference110 articles.

1. Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children

2. Definitions in Hemophilia

3. MASAC: Medical and Scientific Advisory Council Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding). MASAC Recommendation 170. National Hemophilia Foundation 2006. Available from: http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=1007 [last accessed 12 August 2008]

4. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice

5. Brackmann HH, Wallny T. Immune tolerance: high-dose regimen. In: Rodriguez-Merchan EC, Lee CA, editors. Inhibitors in patients with hemophilia. Oxford: Blackwell; 2002. p. 45-8

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Controversies in the Formation and Treatment of Alloantibodies to Factor VIII in Congenital Hemophilia A;Hematology;2011-12-10

2. Immune tolerance induction for patients with severe hemophilia A: a critical literature review;Journal of Thrombosis and Thrombolysis;2011-08-05

3. Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A;Haemophilia;2011-03-30

4. Bleeding Disorders;Pediatric Oncology;2010